Lymphocyte Subpopulations in Spanish Parenteral Drug Addicts

References

• Fahey J L, Prince H, Weaver M, Groopman J, Visscher B, Schartz K, Detels R. Quantitative changes in T helper or T suppressor/cytotoxic lymphocyte subsets that distinguish acquired immune deficiency syndrome from other immune subset disorders. Am J Med 1984; 76: 95–100
   PubMed Web of Science ®Google Scholar
• Fauci A S, Macher A M, Longo D L, Lane H C, Rook A H, Masur H, Gelmann E P. Acquired immunodeficiency syndrome: Epidemiologic, clinical, immunologic and therapeutic considerations. Ann Intern Med 1984; 100: 92–106
   PubMed Web of Science ®Google Scholar
• Gallart T, Anegon I, Cuturi C, Acevedo G, Maragall S, Vila M, Castillo R, Triginer J, Gelabert A, Vives J, Mieras C. T-lymphocyte subpopulations in Spanish haemophiliacs treated with commercial clotting factor concentrate. Antibiot Chemother 1984; 32: 233–240
   Google Scholar
• Goldsmith J C, Moseley P L, Monick M, Brady M, Hunninghake G W. T-lymphocyte subpopulation abnormalities in apparently healthy patients with hemophilia. Ann Intern Med 1983; 98: 294–296
   PubMed Web of Science ®Google Scholar
• Kornfeld H, Vande Stouwe R A, Lange M, Reddy M M, Grieco M H. T-lymphocyte subpopulations in homosexual men. N Engl J Med 1982; 307: 729–731
   PubMed Web of Science ®Google Scholar
• Menitove J E, Aster R H, Casper J T, Lauer S J, Gottschall J L, Williams J E, Gill J C, Wheeler D V, Piaskowski V, Kirchner P, Montgomery R R. T-lymphocyte subpopulations in patients with classic hemophilia treated with cryoprecipitate and lyophilized concentrates. N Engl J Med 1983; 308: 83–86
   PubMed Web of Science ®Google Scholar
• Pinching A J, Jeffries D J, Donaghy M, Munday P E, McManus T J, Moshtael O, Parkin J M, Harris J RW. Studies of cellular immunity in male homosexuals in London. Lancet 1983; 2: 126–129
   PubMed Web of Science ®Google Scholar
• Brown S M, Stimmel B, Taub R N, Kochwa S, Rosenfield R E. Immunologic dysfunction in heroin addicts. Arch Intern Med 1974; 134: 1001–1006
   PubMed Web of Science ®Google Scholar
• McDonough R J, Madden J J, Falek A, Shafer D A, Pline M, Gordon D, Bokos P, Kuehnle J C, Mendelson J. Alteration of T and Null lymphocyte frequencies in the peripheral blood of human opiate addicts: in vivo evidence for opiate receptor sites on T lymphocytes. J Immunol 1980; 125: 2539–2543
   PubMed Web of Science ®Google Scholar
• Gatell J M, Miro J M, Pare C, Garcia S, an Miguel J. Infective endocarditis in drug addicts. Lancet 1984; 1: 228
   PubMedGoogle Scholar
• Lissen E, Wichmann I, Jimenez J M, Andreu-Kern F. AIDS in haemophilia patients in Spain. Lancet 1983; 1: 992–993
   PubMedGoogle Scholar
• Pintor A, Campos L, Cardona P J, Charco R, Marcos E, de Andres N. Sindrome de inmunodeficiencia adquirida: a propósito de un caso en un consumidor de heroina intravenosa. Med Clin (Barc) 1984; 82: 42
   Google Scholar
• Vilaseca J, Arnau J M, Bacardi R, Mieras C, Serrano A, Navarro C. Kaposi's sarcoma and Toxoplasma gondii brain abscess in a Spanish homosexual. Lancet 1982; 1: 572
   PubMedGoogle Scholar
• Jondal M. Rosette formation as human T lymphocyte marker. Lymphocytes: isolation fractionation and characterization, J B Natvig, P Perlmann, H Wigzell. Indre Smaalenenes Trykkeri, Norway 1976; 69–77
   Google Scholar
• Lachmann P J, Hobart M J. Complement Technology 5A-12. Handbook of Experimental Immunology, Blackwell. Scientific Publications, London 1978; 1
   Google Scholar
• Woodroffe A J, Border W A, Theofilopoulos A N, Gotze O, Glassock R J, Dixon F J, Wilson C B. Detection of circulating immune complexes in patients with glomerulonephritis. Kidney Int 1977; 12: 268–278
   PubMedGoogle Scholar
• Center for Disease Control. Update: Acquired immunodeficiency syndrome (AIDS)-United States. MMWR 1984; 33: 337–39
   PubMedGoogle Scholar
• Gallo R C, Salahuddin S Z, Popovic M, Shearer G M, Kaplan M, Haynes B F, Palker T J, Redfield R, Oleske J, Safai B, White G, Foster P, Markham P D. Frequent detection and isolation of cytopathic retrovirus (HTLV-III) from patients with AIDS and at risk for AIDS. Science 1984; 224: 500–502
   PubMed Web of Science ®Google Scholar
• Klatzmann D, Barre-Sinousi F, Nugeyre M T, Dauguet C, Vilmer E, Griscelli C, Brun-Vezinet F, Rouzioux C, Gluckman J C, Chermann J C, Montagnier L. Selective tropism of lymphadenopathy associated virus (LAV) for helper-inducer T lymphocytes. Science 1984; 225: 59–62
   PubMed Web of Science ®Google Scholar
• Metroka C E, Cunningham-Rundles S, Pollack M S, Sonnabend J A, Davis J M, Gordon B, Fernandez R D, Mouradian J. Generalized lymphadenopathy in homosexual men. Ann Intern Med 1983; 99: 585–591
   PubMed Web of Science ®Google Scholar
• Geller S A, Stimmel B. Diagnostic confusion from lymphatic lesions in heroin addicts. Ann Intern Med 1973; 78: 703–705
   PubMedGoogle Scholar
• Simberkoff M S. Infections in parenteral narcotic and drug abusers. Infections in the abnormal host, M H Grieco. Yorke Medical Books. 1980; 508–520
   Google Scholar
• Davis K C, Horsburgh C R, Hasiba U, Schocket A L, Kirkpatrick C H. Acquired immunodeficiency syndrome in a patient with hemophilia. Ann Intern Med 1983; 98: 284–286
   PubMed Web of Science ®Google Scholar
• Alexander G JM, Nouri-Aria K T, Eddleston A LW, Williams R. Contrasting relations between suppressor-cell function and suppressor-cell number in chronic liver disease. Lancet 1983; 1: 1291–1293
   PubMedGoogle Scholar
• Carney W P, Rubin R H, Hoffman R A, Hansen W P, Healey K, Hirsch M S. Analysis of T lymphocyte subsets in cytomegalovirus mononucleosis. J Immunol 1981; 126: 2114–2116
   PubMed Web of Science ®Google Scholar
• Eibl M M, Mannhalter J W, Zlabinger G. Abnormal T-lymphocyte subpopulations in healthy subjects after tetanus booster immunization. N Engl J Med 1984; 310: 198–199
   PubMedGoogle Scholar